Hamlin Capital Management LLC Sells 8,030 Shares of Procter & Gamble Company (The) $PG

Hamlin Capital Management LLC trimmed its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 0.8% during the second quarter, HoldingsChannel.com reports. The fund owned 1,059,367 shares of the company’s stock after selling 8,030 shares during the period. Procter & Gamble makes up approximately 3.5% of Hamlin Capital Management LLC’s investment portfolio, making the stock its 15th biggest holding. Hamlin Capital Management LLC’s holdings in Procter & Gamble were worth $155,346,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of PG. E Fund Management Hong Kong Co. Ltd. raised its holdings in Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Litman Gregory Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $26,000. Park Square Financial Group LLC increased its position in shares of Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after buying an additional 71 shares in the last quarter. Evolution Wealth Management Inc. raised its stake in Procter & Gamble by 1,315.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock worth $26,000 after buying an additional 171 shares during the period. Finally, Basso Capital Management L.P. acquired a new stake in Procter & Gamble during the 4th quarter worth $28,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G agreed to acquire premium supplements company Thorne for $3.8 billion in cash. The transaction expands P&G’s health-care portfolio alongside brands such as Metamucil, Align and New Chapter, and gives the company greater exposure to premium wellness and younger consumers. The deal is expected to close later this year. P&G will acquire supplements brand Thorne
  • Positive Sentiment: Management and Thorne’s owner described the acquisition as a way to build on Thorne’s science-backed brand and growth in wellness. Investors initially viewed the purchase as a strategic move to diversify P&G beyond traditional household and personal-care products. L Catterton announces sale of Thorne to P&G
  • Neutral Sentiment: Trading activity in P&G call options increased, indicating heightened investor interest and potentially more bullish positioning around the acquisition. However, options activity alone does not establish a change in the company’s fundamentals. Traders purchase large volume of P&G call options
  • Negative Sentiment: P&G’s latest quarterly results showed a mixed picture: earnings per share of $1.43 topped estimates by $0.02, but revenue of $21.2 billion missed the $21.38 billion consensus and rose only 1.5% year over year. The sales shortfall and ongoing input-cost pressure may be limiting enthusiasm for the stock. PG Q2 deep dive
  • Negative Sentiment: The $3.8 billion cash purchase creates execution and valuation risk, including the challenge of integrating Thorne and generating sufficient growth from the premium supplement business. Investors may also be assessing the deal’s effect on P&G’s balance sheet and future returns.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Raymond James Financial decreased their target price on Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research note on Tuesday, April 14th. Citigroup cut their price objective on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. BMO Capital Markets boosted their price objective on Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. TD Cowen increased their target price on Procter & Gamble from $142.00 to $150.00 and gave the stock a “hold” rating in a research note on Monday, April 27th. Finally, The Goldman Sachs Group cut their price target on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $161.52.

Get Our Latest Report on PG

Procter & Gamble Stock Down 0.8%

PG stock opened at $146.79 on Thursday. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.68 and a quick ratio of 0.47. The stock has a market capitalization of $341.81 billion, a P/E ratio of 22.17, a P/E/G ratio of 4.55 and a beta of 0.39. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The business has a 50-day moving average of $147.80 and a 200-day moving average of $148.99.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.41 by $0.02. The firm had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. Procter & Gamble had a return on equity of 31.25% and a net margin of 18.44%.The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.71%.

Procter & Gamble Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.